Key Financial Figures

Consolidated Financial Results (₹ lakhs)

  • Total Income: ₹122.76 lakhs
  • Total Expenses: ₹190.96 lakhs
  • Loss before exceptional items and tax: ₹(4.05) lakhs
  • Exceptional items: ₹3.55 lakhs
  • Loss before tax: ₹(19.00) lakhs
  • Tax expense: ₹(1.66) lakhs (Deferred tax)
  • Net loss for period: ₹(41.67) lakhs
  • Total comprehensive income: ₹(4.71) lakhs
  • Paid-up equity share capital: ₹726.32 lakhs (Face value ₹10 each)
  • Weighted average number of equity shares: 54,81,489

Standalone Financial Results (₹ lakhs)

  • Total Income: ₹592.16 lakhs
  • Total Expenses: ₹2,141.57 lakhs
  • Loss before tax and exceptional items: ₹(290.49) lakhs
  • Exceptional items: ₹(19.00) lakhs
  • Loss before tax: ₹(294.72) lakhs
  • Tax expense: ₹4.23 lakhs (Current tax) and ₹(1.32) lakhs (Deferred tax)
  • Net loss for period: ₹(294.72) lakhs
  • Total comprehensive income: ₹(292.56) lakhs
  • Paid-up equity share capital: ₹726.32 lakhs

Segment-wise Performance (Standalone)

Revenue from Operations

  • Cashew processing: ₹81.30 lakhs
  • Tissue Culture: ₹2.09 lakhs
  • Trading: ₹102.55 lakhs
  • Total gross revenue: ₹1,756.67 lakhs
  • Net revenue: ₹1,756.67 lakhs (no inter-segment revenue)

Segment Results (Profit/Loss before interest and tax)

  • Cashew processing: ₹(75.54) lakhs
  • Tissue Culture: ₹(65.91) lakhs
  • Trading: ₹(33.71) lakhs
  • Unallocable: ₹62.70 lakhs

Subsidiary Information

The company disclosed details about three loss-making subsidiaries:

1. Aranya Consulting and Biotech LLP (formerly Aranya Agri Biotech LLP)

  • Accumulated losses: ₹1,494 lakhs as of March 31, 2026
  • Current year loss (up to June 30, 2026): ₹0.69 lakhs
  • Prepared on going concern basis

2. Biospan Scientific LLP

  • Accumulated losses: ₹157 lakhs as of March 31, 2019
  • Management impaired investment of ₹183 lakhs in FY 2018-19 (treated as exceptional item)
  • Prepared on going concern basis as management explores revival possibilities

3. Biospan Contamination Control Solutions Pvt. Ltd

  • Accumulated losses: ₹742 lakhs as of June 30, 2026
  • Total liabilities exceed total assets by ₹752 lakhs
  • Prepared on going concern basis as management believes losses are temporary

Preferential Issue Proceeds Utilization

  • Funds raised: ₹579.36 lakhs through preferential issue
  • Date of allotment: March 28, 2026
  • Utilized amount: ₹372.96 lakhs
  • Unutilized amount: ₹127.04 lakhs
  • Objects of issue: Procurement of Raw Cashew Nut inventory, restart and ramp-up costs, selective refurbishment
  • Status: No deviation or variation in utilization of funds. Unutilized amount will be utilized towards stated objects.

Other Operating Income

Comprises interest on fluctuating capital provided to LLP subsidiaries and management fees income based on subsidiary revenues during the quarter.

Approval and Review Process

  • Financial results approved by Board of Directors on August 11, 2026
  • Board meeting duration: 11:15 IST to 16:30 IST
  • Results reviewed by Audit Committee
  • Limited review reports issued by statutory auditors Y.B. Desai and Associates
  • Results available on company website www.span.in and BSE website

Additional Information

  • Previous periods figures have been regrouped and rearranged wherever necessary
  • Digital signature by Viral Desai, Managing Director (DIN: 00029219)
  • Company address: 9th Floor, Rajhans Bonista, Behind Ram Chowk, Ghod Dod Road, Surat - 395 007, Gujarat